Toxicology and clinical potential of nanoparticles
London Centre for Nanotechnology · University College London · +2 more institutions
Abstract
In recent years, nanoparticles (NPs) have increasingly found practical applications in technology, research and medicine. The small particle size coupled to their unique chemical and physical properties is thought to underlie their exploitable biomedical activities. Here, we review current toxicity studies of NPs with clinical potential. Mechanisms of cytotoxicity are discussed and the problem of extrapolating knowledge gained from cell-based studies into a human scenario is highlighted. The so-called 'proof-of-principle' approach, whereby ultra-high NP concentrations are used to ensure cytotoxicity, is evaluated on the basis of two considerations; firstly, from a scientific perspective, the concentrations…
Citation impact
- FWCI
- 10.92
- Percentile
- 100%
- References
- 165
Authors
4- LYLara Yildirimer
London Centre for Nanotechnology, University College London
- NTNguyen T. K. ThanhCorresponding
Royal Institution of Great Britain, University College London
- MLMarilena Loizidou
University College London, London Centre for Nanotechnology
- AMAlexander M. Seifalian
University College London, Royal Free London NHS Foundation Trust, London Centre for Nanotechnology
Topics & keywords
- Nanomedicine
- Context (archaeology)
- Nanotechnology
- Protocol (science)
- Biochemical engineering
- Cytotoxicity
- Risk analysis (engineering)
- Computer science